senolytic clinical trial ardd agenda
FDA-Bound Or Just A Science Fair? 7 ARDD 2026 Drugs Decoded
Yes, the ARDD 2026 agenda signals that longevity research is shifting from academic showcase to FDA-focused drug development, with seven candidates positioned for regulatory review within the next two years. The meeting’s schedule highlights late-stage trials, FDA participation, and concrete pathways toward market approval. 7 drug programs on the